PDGFRA-D842V | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

123 results for “PDGFRA-D842V”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Active, not recruiting

French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients

25 participants · First posted Jun 15, 2021

Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST

120 participants · First posted Jul 28, 2016

Study of Crenolanib for the Treatment of Patients With Advanced GIST With the D842-related Mutations and Deletions in the PDGFRA Gene

20 participants · First posted Nov 18, 2010

Individual Patient Compassionate Use of Crenolanib

First posted Aug 8, 2018

Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients

1,041 participants · First posted Jun 1, 2022

Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification

11 participants · First posted Dec 10, 2015

Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA

74 participants · First posted Jul 18, 2022

Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors

50 participants · First posted Feb 25, 2021

A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling

29 participants · First posted Feb 26, 2021

Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available

20 participants · First posted Oct 8, 2008

Page 1 of 5